夜盲症治療の世界市場レポート 2025年

夜盲症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.3％で53億9,000万米ドルに成長します。予測期間の成長は、高度な診断技術の採用の増加、目の健康に関する啓蒙活動の増加、個別化医療への需要の高まり、眼科クリニックや施設の数の増加、ヘルスケアインフラ開発の成長に起因しています。予測期間における主な動向には、高度診断技術の採用、個別化治療の実施、遺伝子治療や幹細胞治療の開発、リアルタイムモニタリングのためのウェアラブル技術の統合、多分野にまたがるクリニックの開発などが含まれます。

白内障の罹患率の増加が夜盲症治療市場の拡大を牽引すると予想されます。白内障は、目の水晶体が濁って視力が低下することで発症します。紫外線（UV）への曝露の増加、喫煙、食生活の乱れなどの要因が白内障の開発に寄与します。白内障は、夜間視力に不可欠な明暗を識別する能力を低下させる。このコントラスト感度の低下により、暗い場所での移動や対象物の識別が難しくなります。例えば、2023年7月、英国の政府機関であるWFG（Well-being of Future Generations Act）が実施した2021-23年全国英国眼科医療統計調査によると、2022-23年の白内障入院患者数は約1万6,500人で、前年から23.7％増加しました。その結果、白内障症例の増加が夜盲症治療市場の成長に拍車をかけています。

夜盲症治療市場の主なプレーヤーは、治療成績の向上を目指し、白内障の原因となる遺伝子変異に対処する革新的な遺伝子治療の開発に注力しています。遺伝子治療は、網膜機能に影響を及ぼす特定の遺伝子変異を標的とし修復することで、網膜色素変性症などの遺伝性網膜疾患患者の視力を回復させる可能性があります。例えば、米国を拠点とする臨床段階のバイオテクノロジー企業であるHuidaGene Therapeutics社は、2023年8月にHG004を発表しました。この遺伝子治療は、レーバー先天性黒内障などの遺伝性網膜疾患を治療するためのもので、前臨床試験において既存の治療法よりも優れた結果を示しており、網膜機能の回復と夜盲症の緩和を目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界夜盲症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の夜盲症治療市場：成長率分析
• 世界の夜盲症治療市場の実績：規模と成長, 2019-2024
• 世界の夜盲症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界夜盲症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の夜盲症治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• 手術
• その他の治療法
• 世界の夜盲症治療市場診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液検査
• 色覚検査
• 瞳孔対光反射
• 屈折
• 網膜検査
• 網膜電図（ERG）
• その他の診断
• 世界の夜盲症治療市場症状別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 目の痛み
• 嘔吐
• 曇り空の視界
• ハロー
• 光過敏症
• 遠視の問題
• 頭痛
• その他の症状
• 世界の夜盲症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリニック
• 病院
• その他のエンドユーザー
• 世界の夜盲症治療市場、医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビタミンAサプリメント
• レチノイド療法
• ベータカロチンサプリメント
• 緑内障治療薬
• 世界の夜盲症治療市場、手術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 白内障手術
• 網膜手術
• 角膜移植
• レーシック手術
• 世界の夜盲症治療市場、その他の治療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 光療法
• 遺伝子治療
• 低視力補助具および補助装置
• 栄養療法

第7章 地域別・国別分析

• 世界の夜盲症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の夜盲症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 夜盲症治療市場：競合情勢
• 夜盲症治療市場：企業プロファイル
  • Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boehringer Ingelheim
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Biogen Inc.
• Bausch Health Companies Inc.
• Eisai Co. Ltd
• Cipla Inc.
• Nature's Way
• Spark Therapeutics Inc.
• Garden of Life
• Apellis Pharmaceuticals Inc
• Solgar
• Acucela Inc.
• Swanson Health Products
• NOW Foods

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 夜盲症治療市場2029：新たな機会を提供する国
• 夜盲症治療市場2029：新たな機会を提供するセグメント
• 夜盲症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Night blindness treatment involves interventions designed to address conditions such as vitamin A deficiency and other issues that impair vision in low light conditions. The goal is to improve visual acuity in dim settings and overall visual function by targeting the underlying causes. This treatment aims to enhance the patient's ability to see in low-light environments and at night.

The primary treatments available in the night blindness market include medication, surgery, and other therapies. Night blindness medication focuses on improving vision in low-light conditions by addressing underlying issues such as vitamin A deficiency, retinitis pigmentosa, or other retinal disorders. Diagnosis of night blindness can involve various tests including blood tests, color vision testing, pupil light reflex examination, refraction, retinal exams, and electroretinograms (ERG). Symptoms may include eye pain, vomiting, cloudy vision, halos, light sensitivity, distance vision problems, headaches, and others. The end users of these treatments include clinics, hospitals, and other healthcare facilities.

The night blindness treatment market research report is one of a series of new reports from The Business Research Company that provides night blindness treatment market statistics, including the night blindness treatment industry global market size, regional shares, competitors with night blindness treatment market share, detailed night blindness treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the night blindness treatment industry. These night blindness treatment market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The night blindness treatment market size has grown strongly in recent years. It will grow from $3.95 billion in 2024 to $4.21 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising prevalence of vitamin A deficiency, growth in the geriatric population prone to night vision problems, expansion of healthcare infrastructure, increasing focus on nutritional interventions for vision health, rising incidence of retinitis pigmentosa.

The night blindness treatment market size is expected to see strong growth in the next few years. It will grow to $5.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing adoption of advanced diagnostic technologies, increasing awareness campaigns about eye health, rising demand for personalized medicine, growth in the number of eye care clinics and facilities, growth in healthcare infrastructure development. Major trends in the forecast period include adoption of advanced diagnostic technologies, implementation of personalized treatment, development of gene therapy and stem cell treatments, integration of wearable technology for real time monitoring, development of multi-disciplinary clinics.

The growing incidence of cataracts is anticipated to drive the expansion of the night blindness treatment market. Cataracts occur when the lens of the eye becomes cloudy, impairing vision. Factors such as increased exposure to ultraviolet (UV) light, smoking, and poor diet contribute to cataract development. Cataracts diminish the eye's ability to discern different shades of light and dark, which is essential for night vision. This reduced contrast sensitivity makes it more challenging to navigate and identify objects in low-light settings. For instance, in July 2023, according to the 2021-23 National UK Eye Care Statistics Survey conducted by the Well-being of Future Generations Act (WFG), a UK-based government agency, there were approximately 16,500 cataract admissions in 2022-23, marking a 23.7% increase from the previous year. Consequently, the rise in cataract cases is fueling growth in the night blindness treatment market.

Key players in the night blindness treatment market are focusing on developing innovative genetic therapies to address the genetic mutations causing the condition, aiming to improve treatment outcomes. Genetic therapies target and repair specific genetic mutations affecting retinal function, potentially restoring vision in those with inherited retinal disorders such as retinitis pigmentosa. For instance, HuidaGene Therapeutics, a US-based clinical-stage biotech firm, introduced HG004 in August 2023. This gene therapy is designed to treat inherited retinal diseases such as Leber's congenital amaurosis and has shown superior results over existing treatments in preclinical studies, aiming to restore retinal function and alleviate night blindness.

In January 2022, Eluminex Biosciences, a Chinese biotechnology company, acquired global development and commercialization rights for Zuretinol (zuretinol acetate) from Retinagenix Holdings LLC for an undisclosed sum. This acquisition enables Eluminex Biosciences to enhance its retinal disease pipeline and develop innovative, non-surgical treatments for vision-threatening conditions such as Leber's congenital amaurosis (LCA) and retinitis pigmentosa (RP), offering potential solutions for the entire retina and both eyes simultaneously. Retinagenix Holdings, a US-based company, is also working on treatments for night blindness.

Major companies operating in the night blindness treatment market are Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Bayer AG, Abbott Laboratories, Novartis AG, Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Eisai Co. Ltd, Cipla Inc., Nature's Way, Spark Therapeutics Inc., Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc., Swanson Health Products, NOW Foods

North America was the largest region in the night blindness treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the night blindness treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the night blindness treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The night blindness treatment market consists of revenues earned by entities by providing services such as diagnostic services, medical management and consultation, surgical interventions, and genetic counseling and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The night blindness treatment market also includes sales of night vision goggles, retinal implants and prosthetics, electroretinography (ERG) systems, vitamin A supplements, and intraocular injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Night Blindness Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on night blindness treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for night blindness treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The night blindness treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Medication; Surgery; Other Treatments
• 2) By Diagnosis: Blood Tests; Color Vision Testing; Pupil Light Reflex; Refraction; Retinal Exam; Electroretinogram (ERG); Other Diagnoses
• 3) By Symptom: Eye Pain; Vomiting; Cloudy Vision; Halos; Light Sensitivity; Distance Vision Problem; Headache; Other Symptoms
• 4) By End User: Clinic; Hospital; Other End Users
• Subsegments:
• 1) By Medication: Vitamin A Supplements; Retinoid Therapy; Beta-Carotene Supplements; Anti-Glaucoma Medications; Other Pharmaceutical Treatments
• 2) By Surgery: Cataract Surgery; Retinal Surgery; Corneal Transplantation; LASIK Surgery
• 3) By Other Treatments: Light Therapy; Gene Therapy; Low Vision Aids And Assistive Devices; Nutritional Therapy
• Companies Mentioned: Johnson & Johnson Private Limited; F. Hoffmann-La Roche Ltd.; Bayer AG; Abbott Laboratories; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Night Blindness Treatment Market Characteristics

3. Night Blindness Treatment Market Trends And Strategies

4. Night Blindness Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Night Blindness Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Night Blindness Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Night Blindness Treatment Market Growth Rate Analysis
• 5.4. Global Night Blindness Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Night Blindness Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Night Blindness Treatment Total Addressable Market (TAM)

6. Night Blindness Treatment Market Segmentation

• 6.1. Global Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Surgery
• Other Treatments
• 6.2. Global Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• Color Vision Testing
• Pupil Light Reflex
• Refraction
• Retinal Exam
• Electroretinogram (ERG)
• Other Diagnoses
• 6.3. Global Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Eye Pain
• Vomiting
• Cloudy Vision
• Halos
• Light Sensitivity
• Distance Vision Problem
• Headache
• Other Symptoms
• 6.4. Global Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinic
• Hospital
• Other End Users
• 6.5. Global Night Blindness Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamin A Supplements
• Retinoid Therapy
• Beta-Carotene Supplements
• Anti-Glaucoma Medications
• 6.6. Global Night Blindness Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cataract Surgery
• Retinal Surgery
• Corneal Transplantation
• LASIK Surgery
• 6.7. Global Night Blindness Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Light Therapy
• Gene Therapy
• Low Vision Aids And Assistive Devices
• Nutritional Therapy

7. Night Blindness Treatment Market Regional And Country Analysis

• 7.1. Global Night Blindness Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Night Blindness Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Night Blindness Treatment Market

• 8.1. Asia-Pacific Night Blindness Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Night Blindness Treatment Market

• 9.1. China Night Blindness Treatment Market Overview
• 9.2. China Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Night Blindness Treatment Market

• 10.1. India Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Night Blindness Treatment Market

• 11.1. Japan Night Blindness Treatment Market Overview
• 11.2. Japan Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Night Blindness Treatment Market

• 12.1. Australia Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Night Blindness Treatment Market

• 13.1. Indonesia Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Night Blindness Treatment Market

• 14.1. South Korea Night Blindness Treatment Market Overview
• 14.2. South Korea Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Night Blindness Treatment Market

• 15.1. Western Europe Night Blindness Treatment Market Overview
• 15.2. Western Europe Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Night Blindness Treatment Market

• 16.1. UK Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Night Blindness Treatment Market

• 17.1. Germany Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Night Blindness Treatment Market

• 18.1. France Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Night Blindness Treatment Market

• 19.1. Italy Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Night Blindness Treatment Market

• 20.1. Spain Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Night Blindness Treatment Market

• 21.1. Eastern Europe Night Blindness Treatment Market Overview
• 21.2. Eastern Europe Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Night Blindness Treatment Market

• 22.1. Russia Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Night Blindness Treatment Market

• 23.1. North America Night Blindness Treatment Market Overview
• 23.2. North America Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Night Blindness Treatment Market

• 24.1. USA Night Blindness Treatment Market Overview
• 24.2. USA Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Night Blindness Treatment Market

• 25.1. Canada Night Blindness Treatment Market Overview
• 25.2. Canada Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Night Blindness Treatment Market

• 26.1. South America Night Blindness Treatment Market Overview
• 26.2. South America Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Night Blindness Treatment Market

• 27.1. Brazil Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Night Blindness Treatment Market

• 28.1. Middle East Night Blindness Treatment Market Overview
• 28.2. Middle East Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Night Blindness Treatment Market

• 29.1. Africa Night Blindness Treatment Market Overview
• 29.2. Africa Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Night Blindness Treatment Market Competitive Landscape And Company Profiles

• 30.1. Night Blindness Treatment Market Competitive Landscape
• 30.2. Night Blindness Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Night Blindness Treatment Market Other Major And Innovative Companies

• 31.1. Boehringer Ingelheim
• 31.2. Regeneron Pharmaceuticals Inc.
• 31.3. Astellas Pharma Inc.
• 31.4. Biogen Inc.
• 31.5. Bausch Health Companies Inc.
• 31.6. Eisai Co. Ltd
• 31.7. Cipla Inc.
• 31.8. Nature's Way
• 31.9. Spark Therapeutics Inc.
• 31.10. Garden of Life
• 31.11. Apellis Pharmaceuticals Inc
• 31.12. Solgar
• 31.13. Acucela Inc.
• 31.14. Swanson Health Products
• 31.15. NOW Foods

32. Global Night Blindness Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Night Blindness Treatment Market

34. Recent Developments In The Night Blindness Treatment Market

35. Night Blindness Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Night Blindness Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Night Blindness Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Night Blindness Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer